Guggenheim Starts Arcutis Biotherapeutics Inc. (ARQT) at Buy
Tweet
Share
E-mailGet Alerts ARQT Hot Sheet
Price: $26.19 +1.39%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Guggenheim analyst Seamus Fernandez initiates coverage on Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) with a Buy rating and a price target of $36.00.
For an analyst ratings summary and ratings history on Arcutis Biotherapeutics Inc. click here. For more ratings news on Arcutis Biotherapeutics Inc. click here.
Shares of Arcutis Biotherapeutics Inc. closed at $27.61 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
